The Spine Cage competitive landscape is moderately consolidated, with a handful of global orthopaedic conglomerates accounting for the majority of procedural volume while a long tail of regional manufacturers competes on price and local registration speed. Medtronic, Johnson & Johnson, Stryker, and Zimmer Biomet leverage multi-currency tendering, broad 510(k) portfolios, and surgeon training academies to defend share; mid-tier participants such as NuVasive, Globus Medical, and B. Braun offset scale disadvantages through rapid-cycle titanium/PEEK implant releases, robotic navigation tie-ins, and bundling screws with cages. Competitive levers are shifting from pure pricing toward regulatory agility, as CE mark and FDA clearance timelines increasingly determine who enters tenders first; distribution breadth and hospital payment model alignment now decide repeat volumes more than incremental design tweaks.